GENE ONLINE|News &
Opinion
Blog

Immuno-oncology
Sanofi Looks to Bolster Immunology Pipeline By Acquiring Kymab for $1.5 Billion
2021-01-13
Boehringer Ingelheim’s Newest Acquisition Reinforces its Focus on Immuno-Oncology
2020-12-14
Sanofi Offers to Buy Kiadis Pharma to Advance Immuno-Oncology Research
2020-11-03
FDA Accepts Opdivo, Cabometyx Combo’s Priority Review Applications
2020-10-21
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
Gilead Strikes US$ 4.9B Takeover Deal of Forty Seven
2020-03-02
Merck set to acquire Tilos Therapeutics for $773 million
2019-06-12
Weekly Top 5 in China (0310-0316)
2019-03-19
Weekly Top 5 in China (0217-0223)
2019-02-22
Med X Tech Summit Asia (MEDTEX) 2018 – Overview of Day 1 Program
2018-11-22Partner
Cambridge startup, GO Therapeutics make $195 million deal with Roche
2018-10-05
1 2
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top